Eton Pharmaceuticals, Inc. (ETON)
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. In addition, the company develops Zonisamide Oral Suspension for the treatment of partial on-set seizures; Lamotrigine for Oral Suspension for the treatment of partial on-set seizures; cysteine injection; dehydrated alcohol injection; and Zeneo hydrocortisone autoinjector. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
$152.43M
Mr. Sean E. Brynjelsen
17.00
Deer Park, IL
Nov 09, 2018
-22.69
$-0.26
0.97
1.40
-21.31%
-22.05
-1.75
10.95
4.71
1.28
-21.01%
-43.62%
Similar stocks (17)
Tarsus Pharmaceuticals, Inc.
TARS
Travere Therapeutics, Inc.
TVTX
Replimune Group, Inc.
REPL
Nuvation Bio Inc.
NUVB
Alector, Inc.
ALEC
Celcuity Inc.
CELC
Eliem Therapeutics, Inc.
ELYM
Aldeyra Therapeutics, Inc.
ALDX
Black Diamond Therapeutics, Inc.
BDTX
Inhibrx, Inc.
INBX
Gossamer Bio, Inc.
GOSS
Acumen Pharmaceuticals, Inc.
ABOS
Nuvectis Pharma, Inc.
NVCT
Eledon Pharmaceuticals, Inc.
ELDN
Kronos Bio, Inc.
KRON
Passage Bio, Inc.
PASG
Lyra Therapeutics, Inc.
LYRA
ETF Exposure (12)
iShares Micro-Cap ETF
IWC
0.02501%
Dimensional U.S. Small Cap ETF
DFAS
7.237e-5%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (17)
Tarsus Pharmaceuticals, Inc.
TARS
Travere Therapeutics, Inc.
TVTX
Replimune Group, Inc.
REPL
Nuvation Bio Inc.
NUVB
Alector, Inc.
ALEC
Celcuity Inc.
CELC
Eliem Therapeutics, Inc.
ELYM
Aldeyra Therapeutics, Inc.
ALDX
Black Diamond Therapeutics, Inc.
BDTX
Inhibrx, Inc.
INBX
Gossamer Bio, Inc.
GOSS
Acumen Pharmaceuticals, Inc.
ABOS
Nuvectis Pharma, Inc.
NVCT
Eledon Pharmaceuticals, Inc.
ELDN
Kronos Bio, Inc.
KRON
Passage Bio, Inc.
PASG
Lyra Therapeutics, Inc.
LYRA
ETF Exposure (12)
iShares Micro-Cap ETF
IWC
0.02501%
Dimensional U.S. Small Cap ETF
DFAS
7.237e-5%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%